Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis | Zendy

Chenggang Zhang | Zendy

Open Access

Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl₄-induced liver cirrhosis

Author(s) -

Chenggang Zhang

Publication year - 2016

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.v22.i18.4484

Subject(s) - endocrinology , medicine , hepatic stellate cell , rhoa , agonist , portal venous pressure , portal hypertension , chemistry , masson's trichrome stain , estrogen receptor , cirrhosis , hepatic fibrosis , enos , in vivo , fibrosis , nitric oxide , nitric oxide synthase , biology , receptor , signal transduction , biochemistry , cancer , breast cancer , microbiology and biotechnology

To investigate the role of diarylpropionitrile (DPN), a selective agonist of estrogen receptor β (ERβ), in liver cirrhosis with portal hypertension (PHT) and isolated hepatic stellate cells (HSCs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research